Posted in | News | Ceramic Materials

Increased Capacity for Suriname Alumina Plant

Aug 6 2003

Related Stories

Joint venture partners Alcoa World Alumina and Chemicals and BHP Billiton have approved the expansion to the Paranam alumina refinery in Suriname. After completion, the capacity will be increased by 250,000 metric tonnes per year to 2.2 million metric tonnes per year.

The $65 million project is due to commence immediately and should be completed by July 2005. The expansion project is also expected to bring significant benefits to the Surname economy.

Alcoa World Alumina and Chemicals own 55% of the joint venture, with BHP Billiton owning the remaining 45%. Alcoa World Alumina and Chemicals is a global alliance between Alcoa (60%) and Alumina Ltd (40%).

.

For more information on alumina, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback